# Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol

> **NCT03113409** · PHASE2,PHASE3 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 10 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Naltrexone
- **DRUG:** Vivitrol

## Key facts

- **NCT ID:** NCT03113409
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** no funding available to continue
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113409, "Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03113409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*